BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20947146)

  • 1. XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis.
    Li F; Li C; Jiang Z; Ma N; Gao X
    Urology; 2011 Feb; 77(2):511.e1-5. PubMed ID: 20947146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Li et al.: XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis (Urology 2010;77:511).
    Zou YF; Wang F; Feng XL
    Urology; 2011 Mar; 77(3):766-7; author reply 767-8. PubMed ID: 21377025
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Li et al.: XRCC3 T241M Polymorphism and bladder cancer risk: a meta-analysis (Urology 2011;77:e511-e515).
    Wei B; Xu Z
    Urology; 2011 Jul; 78(1):237-8. PubMed ID: 21712134
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.
    Han S; Zhang HT; Wang Z; Xie Y; Tang R; Mao Y; Li Y
    Eur J Hum Genet; 2006 Oct; 14(10):1136-44. PubMed ID: 16791138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
    He XF; Wei W; Li JL; Shen XL; Ding DP; Wang SL; Liu ZZ; Qin JB; Wu LX; Xie DL
    Gene; 2013 Jul; 523(1):10-9. PubMed ID: 23562721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
    Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
    Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population.
    Zhu X; Zhong Z; Zhang X; Zhao X; Xu R; Ren W; Li S
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):640-3. PubMed ID: 22299591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
    Lao T; Gu W; Huang Q
    Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population.
    Shen H; Wang X; Hu Z; Zhang Z; Xu Y; Hu X; Guo J; Wei Q
    Cancer Lett; 2004 Mar; 206(1):51-8. PubMed ID: 15019159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.
    Jin MJ; Chen K; Song L; Fan CH; Chen Q; Zhu YM; Ma XY; Yao KY
    Cancer Genet Cytogenet; 2005 Nov; 163(1):38-43. PubMed ID: 16271954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
    Karahalil B; Kocabas NA; Ozçelik T
    Anticancer Res; 2006; 26(6C):4955-8. PubMed ID: 17214369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.
    Sun H; Qiao Y; Zhang X; Xu L; Jia X; Sun D; Shen C; Liu A; Zhao Y; Jin Y; Yu Y; Bai J; Fu S
    Cancer Sci; 2010 Aug; 101(8):1777-82. PubMed ID: 20500515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.